| Literature DB >> 31709116 |
Shisheng Ye1, Shiyu Hu1, Zhihao Lei1, Zhichao Li1, Weiping Li1, Yi Sui2, Lijie Ren1.
Abstract
Prehospital delay is one of the major causes of low rate of intravenous recombinant tissue plasminogen activator (rt-PA) thrombolysis for acute ischaemic stroke in China. Regional emergency systems have been proven a successful approach to improve access to thrombolysis. Shenzhen is a high population density city with great geographical disparity of healthcare resources, leading to limited access to rt-PA thrombolysis for most patients with acute ischaemic stroke. To improve rapid access to rt-PA thrombolysis in Shenzhen, a Shenzhen stroke emergency map was implemented by Shenzhen healthcare administrations. This map comprised certification of qualified local hospitals, identification of patients with stroke, acute stroke transport protocol and maintenance of the map. We conducted a retrospective observational study to compare consecutive patients with acute stroke arriving at qualified local hospitals before and after implementation of the Shenzhen stroke emergency map. After implementation of the map, the rate of patients receiving rt-PA thrombolysis increased from 8.3% to 9.7% (p=0.003), and the rate of patients treated with endovascular thrombectomy increased from 0.9% to 1.6% (p<0.001). Sixteen of 20 hospitals have an increase in the number of patients with stroke treated with rt-PA thrombolysis. The median time between receipt of the call and arrival on the scene reduced significantly (17.0 min vs 9.0 min, p<0.001). In Shenzhen Second People's Hospital, the median onset-to-needle time and door-to-needle time were reduced (175.5 min vs 149.5 min, p=0.039; 71.5 min vs 51.5 min, p<0.001). No statistically significant differences were found in the proportion of rt-PA-treated patients within various geographical distances. Currently, there are more than 40 cities in China implementing a stroke emergency map. The Shenzhen stroke emergency map improves access to rt-PA thrombolysis for acute ischaemic stroke, and the novel model has been expanded to multiple areas in China. Future efforts should be conducted to optimise the stroke emergency map. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: acute ischemic stroke; qualified local hospitals; stroke emergency map; thrombectomy; thrombolysis; triage protocol
Year: 2019 PMID: 31709116 PMCID: PMC6812643 DOI: 10.1136/svn-2018-000212
Source DB: PubMed Journal: Stroke Vasc Neurol ISSN: 2059-8696
Figure 1Flow of acute stroke triage protocol. The emergency medical service (EMS) communicators receive the call, recognise the signs and symptoms of stroke, as well as prioritise the nearest ambulance dispatch. After the ambulance arrival on the scene, EMS staff perform and document the results of prehospital stroke identification screen. If stroke is suspected, the time last known well (LKW) is identified and documented. If the LKW is less than 4.5 hours, the patient is transported directly to the nearest qualified hospital and the receiving hospital prenotified. If not, the patient will be transported to the nearest hospital.
Figure 2Initial version of the stroke emergency map. The map only showed hospitals that have thrombolysis capabilities. It showed some large geographical areas with high population density that have no one qualified hospital, such as the northern part of Baoan District, Pingshan District and Dapeng District. Red ‘▲’ indicated qualified hospitals that have stroke care capabilities.
Figure 3Updated version of the stroke emergency map. The map showed hospitals that have thrombolysis and thrombectomy capabilities, newly qualified hospitals (Shenzhen Baoan Second People’s Hospital and Shenzhen Baoan Traditional Chinese Medicine Hospital), and new sites undergoing construction or planned (Shenzhen Songgang People’s Hospital, Shenzhen Pingshan New District People’s Hospital and Shenzhen Dapeng Kuichong People’s Hospital). Red ‘▲’ indicated hospitals that have thrombolysis capabilities. Red ‘★’ indicated hospitals that have both thrombolysis and thrombectomy capabilities. Black ‘▼’ indicated a new site under construction. ‘○’ indicated a new planned site.
Comparison of patients with acute ischaemic stroke before and after implementation of the stroke emergency map
| Before map | After map | P value | |
| Number (%) of patients treated with rt-PA thrombolysis | 568/6843 (8.3) | 802/8268 (9.7) | 0.003 |
| Number (%) of patients treated with endovascular thrombectomy | 60/6843 (0.9) | 136/8268 (1.6) | <0.001 |
| Median time between receipt of the call and arrival on the scene (min) (IQR) | 17.0 (7.0) | 9.0 (3.8) | <0.001 |
| Median onset-to-needle time (min) (IQR) | 175.5 (67.8) | 149.5 (71.8) | 0.039 |
| Median door-to-needle time (min) (IQR) | 71.5 (43.8) | 51.5 (26.8) | <0.001 |
| Number (%) of rt-PA-treated patients within various distances of Shenzhen Second People’s Hospital | |||
| ≤3 km | 10/56 (17.9) | 9/58 (15.5) | 0.738 |
In 20 qualified hospitals, the number of patients with acute stroke treated with rt-PA thrombolysis increased from 568 to 802, and the rate of rt-PA thrombolysis increased from 8.3% to 9.7%. The number of patients treated with endovascular thrombectomy increased from 60 to 136, and the rate of patients treated with endovascular thrombectomy increased from 0.9% to 1.6%. Furthermore, the median time between receipt of the call and arrival on the scene decreased significantly. In Shenzhen Second People’s Hospital, the median onset-to-needle time and door-to-needle time for rt-PA-treated patients decreased by 26 min and 20 min, respectively. The proportion of rt-PA-treated patients within various geographical distances of Shenzhen Second People’s Hospital did not differ significantly.
rt-PA, recombinant tissue plasminogen activator.
Figure 4Comparison of the number of patients treated with rt-PA thrombolysis in 20 qualified hospitals. Sixteen of 20 hospitals had an increase in the number of rt-PA-treated patients, especially Shenzhen Longgang People’s Hospital, University of Chinese Academy of Sciences Shenzhen Hospital and Peking University Shenzhen Hospital, while 4 of 20 hospitals had the opposite result. rt-PA, recombinant tissue plasminogen activator.